TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2012

RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures.

Jason H Mendler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.